EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer

Linlin Li, Ruiyue Zhao, Guochang Wang, Wenbin Jin, Lin Zhu iD, Zhaohui Zhu iD, Hank F Kung iD

Journal of Medicinal Chemistry · 23.07.2026 · 69 (14) · 16268-16278

DOI: 10.1021/acs.jmedchem.6c00960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.07.2026. Verfasst von Linlin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Molecular Imaging Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Beijing Anzhen Hospital High-Level Research Specialized Discipline Construction Project - Nuclear Medicine, Beijing Anzhen Hospital High Level Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsGlutamate Carboxypeptidase IIAntigens, SurfaceRadiopharmaceuticalsTyrosineTheranostic NanomedicineMaleHumansAnimalsLutetium

Substanzen

Glutamate Carboxypeptidase IIAntigens, SurfaceFOLH1 protein, humanRadiopharmaceuticalsTyrosineLutetium

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Molecular Imaging Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
  • Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union, Beijing 100730, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
  • College of Chemistry, Beijing Normal University, Beijing 100875, China.
  • Five Eleven Pharma Inc., 3700 Market St., Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Lin Zhu, Zhaohui Zhu, Hank F Kung

Förderung

  • Beijing Anzhen Hospital High-Level Research Specialized Discipline Construction Project - Nuclear Medicine
  • Beijing Anzhen Hospital High Level Research Funding

Zitieren

APA

Li, L., Zhao, R., Wang, G., Jin, W., Zhu, L., Zhu, Z., & Kung, H. F. (2026). Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. Journal of Medicinal Chemistry, 69(14), 16268-16278. https://doi.org/10.1021/acs.jmedchem.6c00960

Vancouver

Li L, Zhao R, Wang G, Jin W, Zhu L, Zhu Z, et al. Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. Journal of Medicinal Chemistry. 2026;69(14):16268-16278. doi:10.1021/acs.jmedchem.6c00960

BibTeX
@article{Li2026,
  author = {Li, Linlin and Zhao, Ruiyue and Wang, Guochang and Jin, Wenbin and Zhu, Lin and Zhu, Zhaohui and Kung, Hank F},
  title = {Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {14},
  pages = {16268--16278},
  doi = {10.1021/acs.jmedchem.6c00960}
}
Kostenlos starten →